CollPlant Biotechnologies Ltd.
CLGN
Price:
$5
Market Cap:
$57.27M
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair m...[Read more]
Industry
Biotechnology
IPO Date
2018-01-31
Stock Exchange
NASDAQ
Ticker
CLGN
The ROE as of September 2024 (TTM) for CollPlant Biotechnologies Ltd. (CLGN) is -65.98%
According to CollPlant Biotechnologies Ltd.’s latest financial reports and current stock price. The company's current ROE is -65.98%. This represents a change of 290.86% compared to the average of -16.88% of the last 4 quarters.
CollPlant Biotechnologies Ltd. (CLGN) Historical ROE (quarterly & annually)
How has CLGN ROE performed in the past?
The mean historical ROE of CollPlant Biotechnologies Ltd. over the last ten years is -174.95%. The current -65.98% ROE has changed -62.29% with respect to the historical average. Over the past ten years (40 quarters), CLGN's ROE was at its highest in in the September 2019 quarter at 234.04%. The ROE was at its lowest in in the September 2017 quarter at -186.36%.
Average
-174.95%
Median
-130.51%
Minimum
-539.69%
Maximum
0.91%
CollPlant Biotechnologies Ltd. (CLGN) ROE by Quarter and Year
Discovering the peaks and valleys of CollPlant Biotechnologies Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 182.46%
Maximum Annual ROE = 0.91%
Minimum Annual Increase = -5825.34%
Minimum Annual ROE = -539.69%
| Year | ROE | Change |
|---|---|---|
| 2023 | -24.77% | -52.28% |
| 2022 | -51.90% | -5825.34% |
| 2021 | 0.91% | -100.70% |
| 2020 | -129.73% | -63.92% |
| 2019 | -359.52% | 173.83% |
| 2018 | -131.29% | -43.30% |
| 2017 | -231.54% | -57.10% |
| 2016 | -539.69% | 182.46% |
| 2015 | -191.07% | 110.09% |
| 2014 | -90.94% | 48.91% |
CollPlant Biotechnologies Ltd. (CLGN) Average ROE
How has CLGN ROE performed in the past?
The current ROE of CollPlant Biotechnologies Ltd. (CLGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-25.25%
5-year avg
-113.00%
10-year avg
-174.95%
CollPlant Biotechnologies Ltd. (CLGN) ROE vs. Peers
How is CLGN’s ROE compared to its peers?
CollPlant Biotechnologies Ltd.’s ROE is greater than Keros Therapeutics, Inc. (-44.73%), greater than Merus N.V. (-36.33%), less than Vericel Corporation (0.35%), greater than Century Therapeutics, Inc. (-65.37%), greater than Shattuck Labs, Inc. (-68.65%), greater than C4 Therapeutics, Inc. (-44.60%), greater than Eliem Therapeutics, Inc. (-47.03%), greater than Prelude Therapeutics Incorporated (-59.82%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), greater than Molecular Partners AG (-33.08%), greater than MediciNova, Inc. (-13.37%), greater than Anebulo Pharmaceuticals, Inc. (-122.97%), less than Champions Oncology, Inc. (323.52%), greater than Cyteir Therapeutics, Inc. (-23.13%), greater than Replimune Group, Inc. (-52.15%), greater than Crinetics Pharmaceuticals, Inc. (-62.63%), greater than NewAmsterdam Pharma Company N.V. (-81.09%), greater than PureTech Health plc (-29.01%), greater than Ikena Oncology, Inc. (-42.81%), greater than Enochian Biosciences, Inc. (-70.62%), greater than HCW Biologics Inc. (-385.90%), greater than Exicure, Inc. (-288.03%),
| Company | ROE | Market cap |
|---|---|---|
| -44.73% | $2.10B | |
| -36.33% | $3.42B | |
| 0.35% | $2.20B | |
| -65.37% | $136.39M | |
| -68.65% | $177.55M | |
| -44.60% | $433.36M | |
| -47.03% | $549.56M | |
| -59.82% | $143.06M | |
| -70.40% | $359.95M | |
| -33.08% | $172.94M | |
| -13.37% | $89.75M | |
| -122.97% | $54.20M | |
| 323.52% | $71.78M | |
| -23.13% | $108.71M | |
| -52.15% | $703.71M | |
| -62.63% | $4.32B | |
| -81.09% | $1.45B | |
| -29.01% | $469.23M | |
| -42.81% | $83.00M | |
| -70.62% | $45.38M | |
| -385.90% | $22.69M | |
| -288.03% | $3.65M |
Build a custom stock screener for CollPlant Biotechnologies Ltd. (CLGN) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CollPlant Biotechnologies Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
CollPlant Biotechnologies Ltd. (CLGN) and other stocks custom spreadsheet templates
The easiest way to analyze a company like CollPlant Biotechnologies Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is CollPlant Biotechnologies Ltd.'s ROE?
How is the ROE calculated for CollPlant Biotechnologies Ltd. (CLGN)?
What is the highest ROE for CollPlant Biotechnologies Ltd. (CLGN)?
What is the 3-year average ROE for CollPlant Biotechnologies Ltd. (CLGN)?
What is the 5-year average ROE for CollPlant Biotechnologies Ltd. (CLGN)?
How does the current ROE for CollPlant Biotechnologies Ltd. (CLGN) compare to its historical average?